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Background:  The role of glycated hemoglobin (HbA1c) in the prediction of ischemic stroke in non-diabetic subjects is not clear. 
We performed a study to analyze the role of HbA1c in the risk prediction of ischemic stroke in non-diabetic Korean males adult.
Methods:  A total of 307 non-diabetic male patients with ischemic stroke were enrolled, and 253 age-matched control subjects 
without a history of diabetes, hypertension, or cardiovascular disease were selected from a Health Check-up database. Anthro-
pometric measurement data, fasting glucose level, lipid profile, and HbA1c level were available for all subjects. Associations of 
the variables and the presence or absence of ischemic stroke were analyzed.
Results:  The ischemic stroke patient group had significantly higher HbA1c levels (5.8±0.5% vs. 5.5±0.5%, P<0.01) and mean 
systolic and diastolic blood pressure compared with the control group. Among the variables, smoking, low high density lipopro-
tein cholesterol, systolic blood pressure, and HbA1c were the significant determinants for ischemic stroke. The highest quartile 
of HbA1c showed a 9.6-fold increased odds ratio for ischemic stroke compared with the lowest quartile of HbA1c (odds ratio, 
9.596; 95% confidence interval, 3.859 to 23.863, P<0.01). The proportion of ischemic stroke patients showed a significant trend 
for increment as the deciles of HbA1c increased (P for trend <0.01).
Conclusion:  Higher HbA1c indicated a significantly increased risk for ischemic stroke after adjusting for other confounding 
variables in non-diabetic Korean adult males. HbA1c might have significance in predicting the risk for ischemic stroke even in 
the non-diabetic range.
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INTRODUCTION
Stroke is expected to be the second most important cause of 
mortality worldwide by 2020. Approximately 60% of the world’s 
total mortality in 2002 was due to stroke, and in the East Asian 
region, which comprises Southeast Asia and the Western Pa-
cific regions, stroke caused a total 3 million deaths in that year. 
The rapid socioeconomic changes in these regions during re-
cent years have led to changes in lifestyle and diet that can 
greatly influence the risk factors for diseases such as stroke [1].
  Approximately 30% to 40% of acute ischemic stroke patients 
present with hyperglycemia at admission either as a result of 
preexisting diabetes mellitus or acute stress response. Type 2 
diabetes, a disease that affects more than 220 million people 
worldwide, has an alarming number of new cases in the Asian 
population and holds a 2- to 6-fold increased risk for ischemic 
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stroke. Moreover, hyperglycemia is associated with poor out-
come in acute ischemic stroke. Thus, in recent years, there has 
been a growing interest in methods to manage hyperglycemia 
in acute ischemic stroke [2,3].
  Glycated hemoglobin (HbA1c) level reflects the mean glu-
cose control range for the previous 2 to 3 months in patients 
with or without diabetes mellitus. HbA1c level is widely rec-
ommended as the therapeutic guideline for the prevention of 
cardiovascular complications in patients with diabetes [4]. Re-
cently published clinical practice recommendations from the 
American Diabetes Association advocate the use of a HbA1c 
level greater than 6.5% for the diagnosis of diabetes, largely on 
the basis of the established association between HbA1c level 
and microvascular complications. Compared with fasting glu-
cose, HbA1c has higher repeatability, can be tested in a non-
fasting status, and is a relatively stable marker for glucose level. 
The disadvantage of the use of HbA1c in the diagnosis of dia-
betes might be the fact that the measurement of HbA1c level is 
not standardized, which may result in unreliable values in dif-
ferent laboratories and countries [5]. 
  Despite the recent impending increase in risk for diabetes 
and ischemic stroke in Asians, and the increasing importance 
of predictive value of HbA1c in future risk for cardiovascular 
disease, there are no studies that have investigated the associa-
tion of ischemic stroke with HbA1c level in Asians. We cross-
sectionally analyzed the risk for ischemic stroke according to 
HbA1c level in Korean male patients admitted due to acute 
ischemic stroke without a previous history of diabetes.
 
METHODS
Study subjects
This was a case-controlled study in which ischemic stroke pa-
tients were selected from the Soonchunhyang stroke registry 
database. Among 1,685 patients who were admitted to the 
Neurology Department of 3 Soonchunhyang University-affili-
ated Hospitals in Seoul, Bucheon, and Cheonan due to acute 
ischemic stroke from September 2007 to April 2009, a total of 
307 male patients (mean age, 63 years) were selected. All pa-
tients had suffered from focal symptoms and had been observed 
within 1 week of symptom onset and showed relevant lesions 
on magnetic resonance diffusion-weighted imaging (DWI). 
Subjects without fasting blood glucose and HbA1c level data 
were excluded from the study. Patients with a history of diabe-
tes and fasting blood glucose level ≥126 mg/dL were also ex-
cluded from the analyses. Only male adult subjects were se-
lected, and patients with cardioembolic ischemic stroke were 
also excluded from the study. Ischemic stroke subtype was 
classified according to the Trial of Org 10,172 in Acute Stroke 
Treatment (TOAST) criteria [6]. 
  A total of 253 age-matched control male subjects without a 
history of diabetes, hypertension, or cardiovascular disease 
were selected from the Health Check-up database of Kangbuk 
Samsung Hospital Health Promotion Center, Seoul, Korea. The 
purpose of the medical health check-up program is to promote 
the health of employees through regular health check-ups and 
early detection of existing diseases. Most of the examinees are 
employees or family members of various industrial companies 
all around the country. The employer typically pays the cost of 
these medical exams, and a considerable proportion of the ex-
aminees repeat the exam annually or biannually. 
  Case-controlled analyses were performed in these two co-
horts to assess the risk for ischemic stroke according to HbA1c 
category (Fig. 1). The Institutional Review Board of Soonchun-
hyang University Cheonan Hospital approved the protocol and 
data analysis for this study.
Laboratory measurements
Height and weight were measured in duplicate, and the results 
were averaged. Body mass index (BMI) was calculated by di-
1,685 subjects from Soonchunhyang stroke registry database
1,361 subjects
823 subjects
600 subjects
332 subjects
307 subjects
560 subjects (307+253) analyzed
Those without FBS and HbA1c data were excluded
Those with diabetes were excluded
Subjects with FBS ≥126 mg/dL were excluded
Only male subjects were selected
Subjects with cardioembolic stroke were excluded
253 age-matched male control subjects
Fig. 1.  Selection of study subjects.553
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viding the weight (kg) by the height (m) squared. All subjects 
were examined after an overnight fast. The hexokinase meth-
od (Advia 1,650 Autoanalyzer; Bayer Diagnostics, Leverkusen, 
Germany) was used to measure blood glucose level. An enzy-
matic colorimetric test was used to measure total cholesterol 
(TC) and triglyceride concentrations. The selective inhibition 
method was used to measure the level of high density lipopro-
tein cholesterol (HDL-C), and a homogeneous enzymatic ca-
lorimetric test was used to measure the level of low density li-
poprotein cholesterol (LDL-C). 
  HbA1c was measured using an immunoturbidimetric assay 
with a Cobra Integra 800 automatic analyzer (Roche Diagnos-
tics, Basel, Switzerland) with a reference value of 4.4% to 6.4%. 
The methodology was aligned with the Diabetes Control and 
Complications Trial (DCCT) and National Glycohemoglobin 
Standardization Program (NGSP) standards [7]. The intra-as-
say coefficient of variation (CV) was 2.3%, and the inter-assay 
CV was 2.4%, both within NGSP acceptable limits [8].
  Subjects were divided into 4 groups according to the quartiles 
of HbA1c level for the assessment of risk for ischemic stroke: 
1st quartile, HbA1c≤5.3%; 2nd quartile, 5.3<HbA1c≤5.6%; 
3rd quartile, 5.6<HbA1c≤6.0%; and 4th quartile, HbA1c> 
6.0%. In addition, subjects were divided into 10 groups accord-
ing to the decile of HbA1c, and the proportion of the patients 
with ischemic stroke was assessed according to the HbA1c de-
cile.
Statistical analysis
Data are expressed as the subject number with proportion (%) 
and mean with standard deviation. Comparison of the mean 
variables between the ischemic stroke patients and control 
subjects was performed with Student’s t-tests. Logistic regres-
sion analysis with ischemic stroke as the dependent variable 
was performed with age, smoking, body mass index, HDL-C, 
LDL-C, systolic and diastolic blood pressure, and quartile of 
HbA1c included in the model. The proportion of patients with 
ischemic stroke was analyzed according to the decile of HbA1c 
using the chi-square test. Mean values of HbA1c were com-
pared among the groups divided by TOAST classification us-
ing a one-way analysis of variance (ANOVA) test. P values less 
than 0.05 were considered statistically significant.
RESULTS
General characteristics of the participants are presented in Ta-
ble 1. According to TOAST classification, 124 patients (40.39%) 
had large artery disease, 84 (27.36%) had small vessel disease, 
96 (31.27%) had undetermined disease, and 3 (0.98%) had other 
diseases (Fig. 2). Ischemic stroke patients showed a higher mean 
weight and mean HbA1c level compared to control subjects 
(Table 1). Mean values for TC and LDL-C were significantly 
lower in stroke patients, and the mean HDL-C level was sig-
Table 1.  Comparison of mean variables between patients with 
ischemic stroke and control subjects
Variable
Ischemic  
stroke patients 
(n=307)
Control  
subjects 
(n=253)
P value
Age, yr 62.9±13.3 62.3±8.9 0.601
Weight, kg 68.4±16.3 66.1±8.3 0.027
Height, cm 165.3±14.0 167.4±5.6 0.018
BMI, kg/m
2 23.9±2.8 23.5±2.5 0.129
Fasting glucose, mg/dL 100.6±13.8 99.5±10.9 0.306
HbA1c, % 5.8±0.5 5.5±0.5 <0.01
SBP, mm Hg 145.5±24.6 115.7±11.2 <0.01
DBP, mm Hg 88.5±14.5 76.5±7.9 <0.01
TC, mg/dL 179.6±36.9 195.0±35.3 <0.01
Triglyceride, mg/dL 139.6±84.2 132.1±82.6 0.294
HDL-C, mg/dL 45.0±13.0 51.4±12.3 <0.01
LDL-C, mg/dL 106.6±31.9 113.9±27.8 0.004
Smoking, n (%) 157 (51.1) 14 (5.5) <0.01
Values are presented as mean±standard deviation or number (%).
BMI, body mass index; HbA1c, glycated hemoglobin; SBP, systolic 
blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; 
HDL-C, high density lipoprotein cholesterol; LDL-C, low density li-
poprotein cholesterol.
Fig. 2.  Distribution of ischemic stroke patients according to 
TOAST classification. TOAST, Trial of Org 10172 in Acute 
Stroke Treatment. 
Large artery  
disease
Small vessel  
occlusion
Other
Undetermined
31.27%
40.39%
27.36%
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nificantly lower in ischemic stroke subjects compared to con-
trol subjects. The mean systolic and diastolic blood pressure 
values were significantly higher in ischemic stroke patients 
compared to control subjects, and significantly more subjects 
in the ischemic stroke group were smokers compared to the 
control subjects (Table 1). 
  When a logistic regression analysis was performed with 
ischemic stroke as the dependent variable, smoking, HDL-C, 
systolic blood pressure, and increasing HbA1c were the signif-
icant predictors for ischemic stroke development (Table 2). 
Patients who smoked showed a 25-fold increased risk for isch-
emic stroke. After adjustment for confounding variables, pa-
tients in the highest HbA1c quartile showed a nearly 10-fold 
increased risk for ischemic stroke compared with those in the 
lowest HbA1c quartile (Table 2). 
  When the subjects were divided into 10 groups according to 
decile of HbA1c, the proportion of patients with ischemic stroke 
showed a significant trend for increment as the decile of 
HbA1c increased (P for trend <0.01, Fig. 3). 
  When the mean HbA1c values were compared among pa-
tients with ischemic stroke subtypes divided by TOAST classi-
fication, the mean values of HbA1c for patients with ischemic 
stroke due to large artery disease, small vessel disease, other 
disease, and undetermined cause were 5.80±0.46, 5.82±0.58, 
4.90±0.46, and 5.79±0.50%, respectively (P=0.024 by one-way 
ANOVA test). 
DISCUSSION
In this cross-sectional, case-controlled study, patients with 
ischemic stroke showed a significantly increased mean HbA1c 
level compared with those of the age-matched control subjects. 
The odds ratio for ischemic stroke increased as the quartile of 
HbA1c increased from the first to the fourth quartile, and pa-
tients in the highest quartile of HbA1c showed a nearly 10-
fold increased risk for ischemic stroke compared with patients 
in the lowest quartile. The proportion of patients with ischemic 
stroke showed a significantly increasing trend as the HbA1c 
decile increased from the first to the tenth decile, supporting 
the conclusion that higher HbA1c is associated with increased 
risk for ischemic stroke even in the non-diabetic HbA1c range. 
These results suggest a predictive value of increasing HbA1c 
for ischemic stroke risk in non-diabetic Korean male subjects. 
  The International Federation of Clinical Chemistry newly 
defines HbA1c as hemoglobin that is irreversibly glycated at 
one or both of the β-chain N-terminal valines, and it does not 
exclude hemoglobin that is additionally glycated at other sites 
on the α or β chains [9]. HbA1c could reflect universal tissue 
protein glycation and might be a much better index of the 
overall biological effects of glucose above and beyond its pre-
dictive value for the 3-month averages of circulating glucose 
level [10]. Although there are many studies that report the 
utility of HbA1c in predicting cardiovascular disease and dia-
betes, there are few that investigate the usefulness of HbA1c as 
Table 2.  Logistic regression analysis with ischemic stroke as the 
dependent variable
Variable  OR 95% CI P value
Age  0.991 0.963-1.019 0.518
Smoking  25.218 10.725-59.294 <0.01
BMI 0.925 0.820-1.043 0.201
HDL-C  0.961 0.936-0.986 0.003
LDL-C  0.992 0.983-1.002 0.108
SBP 1.123 1.088-1.158 <0.01
DBP 1.016 0.971-1.064 0.489
HbA1c <5.3%  1 - -
5.3< HbA1c≤5.6%  1.450 0.586-3.589 0.422
5.6<HbA1c≤6.0%  4.453 1.903-10.421 0.001
HbA1c>6.0%  9.596 3.859-23.863 <0.01
Adjusted for age, smoking, BMI, HDL-C, LDL-C, SBP, DBP, quartile 
of HbA1c.
OR, odds ratio; CI, confidence interval; BMI, body mass index; HDL-
C, high density lipoprotein cholesterol; LDL-C, low density lipopro-
tein cholesterol; SBP, systolic blood pressure; DBP, diastolic blood 
pressure; HbA1c, glycated hemoglobin. 
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P for trend<0.01
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Fig. 3.  The proportion of subjects with ischemic stroke accord-
ing to HbA1c decile in Korean adult males. HbA1c, glycated 
hemoglobin.555
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a predictor of ischemic stroke.
  Prior studies have demonstrated variable results with regard 
to an association of HbA1c with cardiovascular disease. In the 
Rancho Bernardo cohort of 1,239 older non-diabetic adults, 
baseline HbA1c, but not fasting or post-challenge glucose, pre-
dicted cardiovascular mortality in women but not in men [11]. 
In the EPIC-Norfolk study, a 1% increment in HbA1c was as-
sociated with a 21% increase in cardiovascular risk after multi-
variable adjustment in both men and women. However, when 
subjects with prior diabetes and cardiovascular disease were 
excluded, this association was diminished and not statistically 
significant [12]. In the Hoorn Study, which also presented cat-
egorical analyses with and without adjustment for traditional 
risk factors, the age-adjusted risk in the highest vs. lowest cate-
gory (≥6.5% vs. <5.2%) was 3.8. However, after additional ad-
justment for gender, hypertension, dyslipidemia, and smok-
ing, this effect was attenuated and no longer statistically signif-
icant [13]. In a nested case-controlled study in the Women’s 
Health Study cohort, HbA1c level was not predictive of car-
diovascular events after adjustment for confounding effects of 
correlated cardiovascular risk factors [14]. In a previous study 
performed in 26,563 U.S. female health professionals with a 
follow-up period of 10 years, HbA1c failed to predict cardio-
vascular disease in non-diabetic women [15]. 
  On the other hand, a previous study using a case-cohort de-
sign found associations of HbA1c with coronary heart disease 
and stroke in a subgroup of the ARIC population with low 
fasting glucose levels (at two time points) and low HbA1c val-
ues among persons with diabetes [16,17]. In a very recent study 
from a community-based population of non-diabetic adults 
followed-up for 14 years, HbA1c was significantly associated 
with a future risk for diabetes, cardiovascular disease, and 
death from any cause as compared with fasting glucose. In this 
study, subjects with a baseline level of HbA1c between 5.0% 
and 5.5% were compared with subjects having higher HbA1c 
values, and their risk for ischemic stroke linearly increased as 
the baseline level of HbA1c increased. These significances were 
more prominent in HbA1c values compared with fasting glu-
cose. Despite significant differences between blacks and whites 
in HbA1c value at baseline, race did not modify the associa-
tion among HbA1c value, cardiovascular outcome and death 
in this population [18]. There have also been a few studies per-
formed in non-diabetic Korean adults reporting the associa-
tion between the risks for coronary artery disease or metabolic 
syndrome [19,20], but no studies were performed on the asso-
ciation of HbA1c and the risk for ischemic stroke in Koreans. 
  We analyzed the risk for ischemic stroke only in male adults 
because we wanted to determine if there were any gender dif-
ferences considering that HbA1c failed to predict cardiovas-
cular disease in non-diabetic women [15]. We also failed to 
show the usefulness of HbA1c as a predictor of ischemic stroke 
in non-diabetic Korean women. This result might be due to a 
lack of consideration for hormonal change or hormonal re-
placement therapy in postmenopausal women. Recent studies 
reported that sex hormone and sex hormone-binding globu-
lin, in addition to HbA1c, are associated with a risk of type 2 
diabetes [21,22]. Because the average age of women in our 
study was in the sixties, and they were mostly postmenopausal 
women having severe hormonal change, it might be difficult 
to show the association of HbA1c as a predictor of ischemic 
stroke.
  Our study has several limitations. First, it was a cross-sec-
tional study such that a definite relationship between HbA1c 
and ischemic stroke cannot be assumed. Further research in a 
more diverse ethnic group must be conducted to clarify this 
relationship. Second, this study might cause controversy about 
the representativeness of stroke patients. However, our objects 
of study were stroke patients from 3 different regions repre-
senting a large city, a medium-sized city, and a rural area, re-
spectively. The characteristics of stroke patients in this study 
were similar to those of nationwide Korean Stroke Registry 
data, so the groups of patients in this study could be represen-
tative of stroke patients in Korea to some extent. Third, ac-
cording to the classification of ischemic stroke subtype in this 
study, the number of patients with cardioembolic ischemic 
stroke was smaller than usual, which might be explained be-
cause studies for cardiac source of ischemic stroke were insuf-
ficient. Fourth, the mean values for TC and LDL-C were sig-
nificantly lower in stroke patients, and these differences might 
be assumed to be due to the higher percentage of lipid-lower-
ing medications used in this study population. Fifth, the diag-
nosis of type 2 diabetes was only based on the levels of fasting 
glucose and HbA1c without a glucose challenge test. There-
fore, there is still the possibility that subjects with overt diabe-
tes could have been included in this study, although recent 
guidelines recommend that fasting glucose and HbA1c levels 
are sufficient to diagnose diabetes [5]. In spite of these limita-
tions, the results of this study are meaningful in that this study 
was the first to report the association of increasing HbA1c 
with risk for ischemic stroke in non-diabetic Korean adults.556
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  In conclusion, higher HbA1c indicated a significantly in-
creased risk for ischemic stroke after adjusting for other con-
founding variables in non-diabetic Korean adult males. In ad-
dition, HbA1c might have significance in predicting the risk 
for ischemic stroke even in the non-diabetic range. Therefore, 
efforts to maintain glucose level within the normal range in 
subjects with high cardiovascular risk are important. These 
data support the need for a prospective study examining levels 
of HbA1c and future ischemic stroke in Korean subjects.
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